Document is current

Article History

Received: 23 October 2024

Accepted: 3 February 2025

First Online: 22 February 2025

Declarations

:

: Julian Witte, Manuel Batram, and Bastian Surmann are employees by Vandage, which received funding from GSK to perform the study related to this manuscript. They declare that Vandage received payments from GSK, Janssen-Cilag GmbH, Sanofi-Aventis Deutschland GmbH, Viatris, Seqirus GmbH, MSD Sharp & Dohme GmbH, Moderna, Pfizer Pharma GmbH, AstraZeneca GmbH for grant. Vandage received payments from Pfizer Pharma, AstraZeneca for support for attending meetings and/or travel, and has received travel expense reimbursements for attending meetings and/or travel from GKV Spitzenverband and Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen. Vandage received consulting fees and grants from AOK Rheinland/Hamburg, BARMER, DAK-Gesundheit, German Federal Joint Committee, and Techniker Krankenkasse for sickness funds. Pavo Marijic and Christian Rauschert are employed by GSK. Johannes Hain is employed by GSK and holds financial equities in GSK. Christian Maihöfner declares having received grants or contracts from STEADTLER Foundation and consulting fees and honoraria from Daiichi Sankyo, Bionorica ethics, Novartis, GSK, HALEON, Lilly, Grünenthal. He had been the Head of Education Academy for the German Pain Society. Philipp Stahl declares having received payment for presentations from GSK. Helmut Schöfer has received consulting fees and payments for advisory board from GSK, for consulting from Tiefenbacher Pharma, and for annual advisory from Novartis. He has received payment for presentations and support for attending meetings and/or travel from GSK, Novartis, DERGO GBR (Essen), CRM, International Society of Dermatology in the Tropics, EADV, Deutsche Gesellschaft für Innere Medizin, Interplan Congress, Landesärztekammer Hessen, ADI-TD, Akademie, Landesapothekerkammer Hessen, RG Ärztefortbildung, Austrian Society for Travel and Touristic Medicine, and from DDG. Christiane Hermann has received from GSK a payment or honoraria for webinars by GSK, support for attending scientific conference, and payment as advisory board member. Marie Nishimwe has received consulting fees to contribute to this study as an AIXIAL consultant for GSK and then received payment as a GSK employee. Ursula Marschall is an employee of BARMER Statutory Health Insurance Fund. The authors declare no other financial and non-financial relationships and activities.

: The study relied on anonymized patient claims data and was conducted according to general data protection rules and the ethical principles of the Declaration of Helsinki. The study was non-interventional and did not require review or approval by an ethics committee in line with the national guidelines, ‘Good practice for secondary data analysis’ [].